Get startedLog in
    Picture of Horizon Therapeutics logo

    HZNP — Horizon Therapeutics Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareBalancedLarge Cap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Horizon Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

    2018
    December 31st
    2019
    December 31st
    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:10-K10-K10-K10-K10-K
    Standards:
    USG
    USG
    USG
    USG
    USG
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-74.2573390534521
    Depreciation
    Deferred Taxes
    Non-Cash Items202184266310308
    Unusual Items
    Purchased R&D
    Other Non-Cash Items
    Changes in Working Capital-144-2.5-346-61.7-12
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Accounts Payable
    Change in Accrued Expenses
    Change in Other Liabilities
    Net Change in Other Assets & Liabilities
    Cash from Operating Activities1954265561,0351,258
    Capital Expenditures-4.77-17.9-170-76.6-64
    Purchase of Fixed Assets
    Other Investing Cash Flow Items32.40-294-2,918-70
    Acquisition of Business
    Sale of Business
    Sale of Fixed Assets
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities27.7-17.9-464-2,994-134
    Financing Cash Flow Items-14.5-28.3-66.5-166-137
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-16.6-2909051,470-348
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash2041181,003-499773